Bates AS - Search Results

1

Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.

Bates AS, Evans AJ, Jones P, Clayton RN. Bates AS, et al. Clin Endocrinol (Oxf). 1995 Apr;42(4):417-23. doi: 10.1111/j.1365-2265.1995.tb02651.x. Clin Endocrinol (Oxf). 1995. PMID: 7750196

2

Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.

Sherlock M, Aragon Alonso A, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM. Sherlock M, et al. Clin Endocrinol (Oxf). 2009 Jul;71(1):74-81. doi: 10.1111/j.1365-2265.2008.03461.x. Epub 2008 Oct 26. Clin Endocrinol (Oxf). 2009. PMID: 19178529

3

A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.

Sherlock M, Reulen RC, Aragon-Alonso A, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM. Sherlock M, et al. Among authors: bates as. J Clin Endocrinol Metab. 2014 Feb;99(2):478-85. doi: 10.1210/jc.2013-2450. Epub 2013 Nov 15. J Clin Endocrinol Metab. 2014. PMID: 24243636

4

Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion.

Bates AS, Evans AJ, Jones P, Clayton RN. Bates AS, et al. Clin Endocrinol (Oxf). 1995 Apr;42(4):425-30. doi: 10.1111/j.1365-2265.1995.tb02652.x. Clin Endocrinol (Oxf). 1995. PMID: 7750197

5

An audit of outcome of treatment in acromegaly.

Bates AS, Van't Hoff W, Jones JM, Clayton RN. Bates AS, et al. Q J Med. 1993 May;86(5):293-9. Q J Med. 1993. PMID: 8327647

6

The effect of hypopituitarism on life expectancy.

Bates AS, Van't Hoff W, Jones PJ, Clayton RN. Bates AS, et al. J Clin Endocrinol Metab. 1996 Mar;81(3):1169-72. doi: 10.1210/jcem.81.3.8772595. J Clin Endocrinol Metab. 1996. PMID: 8772595

7

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.

Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. Ayuk J, et al. Among authors: bates as. J Clin Endocrinol Metab. 2004 Apr;89(4):1613-7. doi: 10.1210/jc.2003-031584. J Clin Endocrinol Metab. 2004. PMID: 15070920

8

Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.

Sherlock M, Fernandez-Rodriguez E, Alonso AA, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM. Sherlock M, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1255-63. doi: 10.1210/jc.2008-1420. Epub 2009 Jan 21. J Clin Endocrinol Metab. 2009. PMID: 19158203

9

Clinical and genetic changes in a case of a Cushing's carcinoma.

Bates AS, Buckley N, Boggild MD, Bicknell EJ, Perrett CW, Broome JC, Clayton RN. Bates AS, et al. Clin Endocrinol (Oxf). 1995 Jun;42(6):663-70; discussion 671-2. doi: 10.1111/j.1365-2265.1995.tb02697.x. Clin Endocrinol (Oxf). 1995. PMID: 7634510

10

P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas.

Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. Buckley N, et al. Among authors: bates as. J Clin Endocrinol Metab. 1995 Feb;80(2):4 p following 692. doi: 10.1210/jcem.80.2.7852482. J Clin Endocrinol Metab. 1995. PMID: 7852482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters